191 related articles for article (PubMed ID: 34117308)
1. HSP-90/kinase complexes are stabilized by the large PPIase FKB-6.
Sima S; Barkovits K; Marcus K; Schmauder L; Hacker SM; Hellwig N; Morgner N; Richter K
Sci Rep; 2021 Jun; 11(1):12347. PubMed ID: 34117308
[TBL] [Abstract][Full Text] [Related]
2. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
[TBL] [Abstract][Full Text] [Related]
3. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
[TBL] [Abstract][Full Text] [Related]
4. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
Stetz G; Verkhivker GM
J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
[TBL] [Abstract][Full Text] [Related]
5. Exploring Mechanisms of Communication Switching in the Hsp90-Cdc37 Regulatory Complexes with Client Kinases through Allosteric Coupling of Phosphorylation Sites: Perturbation-Based Modeling and Hierarchical Community Analysis of Residue Interaction Networks.
Stetz G; Astl L; Verkhivker GM
J Chem Theory Comput; 2020 Jul; 16(7):4706-4725. PubMed ID: 32492340
[TBL] [Abstract][Full Text] [Related]
6. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
Czemeres J; Buse K; Verkhivker GM
PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide-Free sB-Raf is Preferentially Bound by Hsp90 and Cdc37 In Vitro.
Eckl JM; Daake M; Schwartz S; Richter K
J Mol Biol; 2016 Oct; 428(20):4185-4196. PubMed ID: 27620500
[TBL] [Abstract][Full Text] [Related]
8. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
Gaiser AM; Kretzschmar A; Richter K
J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.
Miyata Y
Cell Mol Life Sci; 2009 Jun; 66(11-12):1840-9. PubMed ID: 19387550
[TBL] [Abstract][Full Text] [Related]
10. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
11. Functions of the Hsp90-binding FKBP immunophilins.
Guy NC; Garcia YA; Sivils JC; Galigniana MD; Cox MB
Subcell Biochem; 2015; 78():35-68. PubMed ID: 25487015
[TBL] [Abstract][Full Text] [Related]
12. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
[TBL] [Abstract][Full Text] [Related]
14. Structure of an Hsp90-Cdc37-Cdk4 complex.
Vaughan CK; Gohlke U; Sobott F; Good VM; Ali MM; Prodromou C; Robinson CV; Saibil HR; Pearl LH
Mol Cell; 2006 Sep; 23(5):697-707. PubMed ID: 16949366
[TBL] [Abstract][Full Text] [Related]
15. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.
Verma S; Singh A; Mishra A
J Mol Graph Model; 2012 Jul; 37():27-38. PubMed ID: 22609743
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function.
Wang L; Li L; Gu K; Xu XL; Sun Y; You QD
Curr Drug Targets; 2017; 18(13):1572-1585. PubMed ID: 27231111
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40.
Pirkl F; Buchner J
J Mol Biol; 2001 May; 308(4):795-806. PubMed ID: 11350175
[TBL] [Abstract][Full Text] [Related]
19. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
[TBL] [Abstract][Full Text] [Related]
20. The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state.
Lee K; Thwin AC; Nadel CM; Tse E; Gates SN; Gestwicki JE; Southworth DR
Mol Cell; 2021 Sep; 81(17):3496-3508.e5. PubMed ID: 34380015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
